Michael Sweeney M.D., CMO and VP, R&D at DEPOMED INC (DEPO), sold 4,270 shares at $8.40 ($36K) on 2013-12-02, disclosed to the SEC on 2013-12-04.
Scheduled sale ($36k) by CMO and VP, R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| DEPO | SELL | 2011-06-15 | $48K | — | Filing → |